uniQure Announces Will Lewis as New Board Member
June 12, 2014 06:15 ET
|
uniQure
AMSTERDAM, Netherlands, June 12, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that Will Lewis has joined uniQure's Supervisory Board as of June...
uniQure Announces Results for the First Quarter 2014
June 06, 2014 05:11 ET
|
uniQure
--Platform Positioned to Develop the Next Generation of Novel Gene Therapies--
AMSTERDAM, The Netherlands, June 6, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene...
uniQure Announces Analysis of Six-Year Follow-up Data for Glybera(R)
June 03, 2014 11:13 ET
|
uniQure
--50% Fewer Pancreatitis Events, No Severe Pancreatitis Post One-time Treatment--
AMSTERDAM, The Netherlands, June 3, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene...
uniQure and Medison Sign Glybera(R) Distribution Agreement for Israel
May 29, 2014 05:04 ET
|
uniQure
AMSTERDAM, The Netherlands and PETACH TIKVA, Israel, May 29, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading...
uniQure Announces Successful Transfection of Liver Cells with AAV5 and Strong Safety Data from Acute Intermittent Porphyria Clinical Trial
May 27, 2014 05:10 ET
|
uniQure
--Phase I Interim Results of AMT-021 Presented at ASGCT Conference--
AMSTERDAM, The Netherlands, May 27, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today...
uniQure to Present at the BioEquity Europe and Jefferies Global Healthcare Conferences
May 15, 2014 05:18 ET
|
uniQure
AMSTERDAM, The Netherlands, May 15, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
uniQure Announces Changes in Management Team
April 09, 2014 07:03 ET
|
uniQure
AMSTERDAM, The Netherlands, April 9, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the appointment of Eric Goossens as its new Chief Operating...
uniQure Announces Results for Financial Year 2013
March 26, 2014 08:12 ET
|
uniQure
AMSTERDAM, The Netherlands, March 26, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced unaudited results for the financial year ended December 31,...
uniQure to Present at Future Leaders in Biotech Conference
March 21, 2014 11:34 ET
|
uniQure
Amsterdam, The Netherlands, March 21, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the...
uniQure and Chiesi Announce Six Year Follow-up Data from Glybera(r) Treated Patients
March 17, 2014 06:18 ET
|
uniQure
AMSTERDAM, Netherlands, March 17, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, and Chiesi Farmaceutici S.p.A. ("Chiesi"), a leading international...